NDC Active Ingredient Alemtuzumab

Active Ingredient Information

What is Alemtuzumab?

An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.

What is the usage for Alemtuzumab?

Alemtuzumab is used to treat multiple sclerosis (MS). It is not a cure for MS but it is thought to help by preventing immune system cells (lymphocytes) from attacking the nerves in your brain and spinal cord. It helps decrease the number of relapses and may prevent or delay disability.

How many products in the NDC database contain Alemtuzumab?

The NDC database has 2 products with the active ingredient Alemtuzumab. The following table lists all the products that have this active ingredient.

NDC Products with Alemtuzumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
58468-0200Proprietary Name: Lemtrada AlemtuzumabInjection, Solution, ConcentrateIntravenousGenzyme CorporationACTIVE
58468-0357Proprietary Name: Campath AlemtuzumabInjectionIntravenousGenzyme CorporationACTIVE